The Tropical Disease market is a subset of the Pharmaceuticals industry that focuses on the development of treatments for diseases that are endemic to tropical and subtropical regions. These diseases are caused by a variety of pathogens, including viruses, bacteria, fungi, and parasites. The market is driven by the need to address the high burden of disease in these regions, as well as the potential for new treatments to be developed for diseases that are not yet treatable. The Tropical Disease market is highly competitive, with a number of large pharmaceutical companies and smaller biotechnology firms vying for market share. Companies in the market include GlaxoSmithKline, Merck, Novartis, Sanofi, Pfizer, Johnson & Johnson, and Bristol-Myers Squibb. Additionally, there are a number of smaller biotechnology companies that are focused on developing treatments for tropical diseases, such as Gilead Sciences, Inovio Pharmaceuticals, and Moderna Therapeutics. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
